Site selection and recruitment plans based on indirect data sources that, due to regulations, cannot identify the ... TI
TRANSFORMING ONCOLOGY TRIAL PATIENT RECRUITMENT WITH COGNITIVE COMPUTING
PATIENT RECRUITMENT TODAY IS BROKEN
U.S.A
32%
DRUG DEVELOPERS SPEND
$1.2 BILLION
Cost per completed patient can reach $1,3003
Recruitment demands 32% of a trial’s budget2
ON PATIENT RECRUITMENT1 EVERY YEAR
71%
20%
PAUCITY OF PATIENTS REQUIRED EXTENDING THE AVERAGE ONCOLOGY TRIAL’S RECRUITMENT PERIOD BY 71%4
After timeline extension, 20% of sites still failed to reach goals or even enroll a single patient4
Each day of delay sacrifices between $600,000 to $8,000,000 in revenue5
RECRUITMENT BY ADVERTISEMENT IS DIFFICULT TO PREDICT HOW CLINICAL TRIALS FIND PATIENTS Site selection and recruitment plans based on indirect data sources that, due to regulations, cannot identify the actual patients
Laboratory testing results
Longitudinal clinical data
Prescriptions at pharmacies
Patient advocacy groups
Online patient communities
Insurance claims
Manual EMR review
HOW PATIENTS FIND CLINICAL TRIALS Advertisements push patients to doctors
Online presence
Direct mail
Video
Social media
Text messages
ENROLLMENT FREQUENTLY FALLS SHORT OF ESTIMATES
Site A - 12/18
Site C - 29/40
Site B - 22/30
Site D - 18/18
Pharmacy alliances
Advocacy groups
Print ads
Print collateral
ONCOLOGISTS ARE HAVING A HARDER TIME FILLING IN THE GAPS
Site E - 40/40
50%
OF PHYSICIANS REPORT STAYING CURRENT ON CLINICAL TRIALS6
79%
OF PATIENTS LOOK TO ONCOLOGISTS TO IDENTIFY PERTINENT CLINICAL TRIALS6
MANY ONCOLOGISTS SEE OVER
80
CANCER PATIENTS EACH MONTH6
88% OF ONCOLOGISTS’ TIME DEDICATED TO PATIENT CARE6
ELIGIBILITY CRITERIA TO REVIEW HAVE SKYROCKETED
62%
IN THE LAST DECADE (2002:31, 2012: 501)
ICON-IBM WATSON PILOT PROGRAM & THE FUTURE OF CLINICAL TRIAL RECRUITMENT & PLANNING
Identifies patients who match a study’s inclusion and exclusion criteria
